Studying CNS injury or astrocyte activation? Our latest #CSTblog covers key astrocyte and glial markers and strategies for using multiplex IF for astrogliosis research. hubs.ly/Q03KPP9W0

Avoid CAR Trouble with Posibeads™ positive control beads. 🏎️✨ Not sure if low #flowcytometry signal is due to poor immunostaining or a lack of CAR expression? Learn how to take the guesswork out of your data interpretation in this #CSTblog. hubs.ly/Q03zkXJp0

Parkinson’s research is evolving—fast. CST Associate Director of Neuroscience Richard W. Cho explores 10 key biomarkers linked to PD diagnosis, disease progression, and mitochondrial dysfunction on the #CSTBlog. Read it now 👇 hubs.ly/Q03tNPl30

🛠️🚙Give your CAR experiments a tune-up. Add Posibeads™ Positive Control Beads to your CAR workflow. Learn how Posibeads can streamline your flow cytometry experiments in this #CSTblog. hubs.ly/Q03yvXy30

🧪 What makes a research antibody reliable? Orthogonal data helps. 👩‍🔬🔬 Learn how CST scientists use orthogonal data sources like RNA-seq and mass spec to confirm antibody specificity on the #CSTblog: hubs.ly/Q03vBK-l0

🧠 From α-synuclein to LRRK2, CST Associate Director of Neuroscience @RichardWCho breaks down 10 biomarkers in Parkinson’s disease research—and the antibody tools to study them. 🧰 Explore your PD research toolbox on the #CSTBlog: hubs.ly/Q03tBmLV0

🔬💡Epithelial-mesenchymal transition (EMT) is key to tackling cancer metastasis & treatment resistance. Our latest #CSTblog explores the most important EMT markers, including E-cadherin, N-cadherin, vimentin, and more, and how they’re shaping the... hubs.ly/Q03qHTDy0

🔬How does the extracellular matrix (ECM) influence cancer progression in the tumor microenvironment (TME)? Explore key markers and the antibody tools researchers are using to study tumor growth, immune evasion, and drug resistance on the #CSTBlog: hubs.ly/Q03pw4PS0

✅ 🧬 Cross-validation using orthogonal data sources adds rigor and reproducibility to your antibody validation workflows. Learn how CST scientists use orthogonal data sources like RNA-seq and mass spec to confirm antibody specificity on the #CSTblog hubs.ly/Q03fBFjg0

🧠🔬 Explore key biofluid targets for AD, PD, ALS, and more—plus the antibodies and ELISA kits to detect them on the #CSTblog: hubs.ly/Q03mvYBZ0

Is your research antibody reliable? CST Principal Scientist Srikanth Subramanian explains how we collaborate with @YCharOS1 for independant antibody validation on the #CSTBlog. hubs.ly/Q03lrM_p0

🔬💡mRNA ≠ protein. Learn why transcript levels don’t tell the whole story—and what measuring intracellular PTMs along with mRNA can reveal about single cell signaling on the #CSTBlog: hubs.ly/Q03jxtMn0

Solid tumors are a major hurdle for CAR cell therapy research. Learn how the Whitlow/218 anti-CAR linker antibody can help track CAR cell infiltration and persistence in IHC assays on the #CSTBlog: hubs.ly/Q03hC-zd0

🔬🧐 Are you using a flawed Bax antibody? A widely used reagent may be binding to the wrong protein—costing millions in wasted research & calling into question the validity of over 1,500 peer-reviewed studies. Read the #CSTBlog: hubs.ly/Q03gBC6f0

🌿🗣️ This #EarthMonth, learn why tropical forests are one of our best defenses against climate change from guest blogger Greg Powell of @ReforestTropics & why CST is a proud sponsor of a 25-year reforestation project in Costa Rica on the #CSTBlog: hubs.ly/Q03fzSpt0

When >50% of research reagents reportedly don’t perform as promised by manufacturers, how can you be sure your antibody will work? Explore tips for selecting the right reagent on the #CSTblog: hubs.ly/Q038pNcf0

🔬 🧬 What if you could measure RNA, cell type & intracellular signaling at the single cell level? Researchers have long attempted such a scRNA-seq assay, but methodologies often lack reproducibility. Learn more about the InTraSeq assay on the #CSTBlog: hubs.ly/Q037mQ5q0

Does the InTraSeq assay really work? The data says yes! ✅ Preserves RNA integrity & cellular heterogeneity ✅ Detects both intracellular & surface proteins ✅ Is sensitive and reproducible Still skeptical? 🧐 Read the #CSTblog t... hubs.ly/Q036qt8b0

New on the #CSTblog: TREM2 signaling antibody toolkit! Whether validating #microglia purity or assessing TREM2 & DAP12 interactions, this antibody toolkit will help unlock neuroinflammatory signaling insights. blog.cellsignal.com/microglia-acti…

🎯Are your flow cytometry data accurate? Our latest #CSTBlog has answers to common troubleshooting questions such as: - When should I use Fc block? - How do I fix and permeabilize cells? - How do I confirm cell viability? 👉Read it now: hubs.ly/Q02X88lD0